Logo image of NYT

NEW YORK TIMES CO-A (NYT) Stock Fundamental Analysis

NYSE:NYT - New York Stock Exchange, Inc. - US6501111073 - Common Stock - Currency: USD

55.41  +0.52 (+0.95%)

After market: 55.41 0 (0%)

Fundamental Rating

6

Overall NYT gets a fundamental rating of 6 out of 10. We evaluated NYT against 96 industry peers in the Media industry. NYT has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. NYT is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

NYT had positive earnings in the past year.
In the past year NYT had a positive cash flow from operations.
Each year in the past 5 years NYT has been profitable.
In the past 5 years NYT always reported a positive cash flow from operatings.
NYT Yearly Net Income VS EBIT VS OCF VS FCFNYT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

The Return On Assets of NYT (11.08%) is better than 94.79% of its industry peers.
The Return On Equity of NYT (16.07%) is better than 86.46% of its industry peers.
NYT has a better Return On Invested Capital (13.68%) than 96.88% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NYT is above the industry average of 6.73%.
The 3 year average ROIC (11.43%) for NYT is below the current ROIC(13.68%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 11.08%
ROE 16.07%
ROIC 13.68%
ROA(3y)8.59%
ROA(5y)7.74%
ROE(3y)13.1%
ROE(5y)12.23%
ROIC(3y)11.43%
ROIC(5y)10.49%
NYT Yearly ROA, ROE, ROICNYT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

NYT has a Profit Margin of 11.53%. This is amongst the best in the industry. NYT outperforms 87.50% of its industry peers.
NYT's Profit Margin has improved in the last couple of years.
The Operating Margin of NYT (14.78%) is better than 79.17% of its industry peers.
NYT's Operating Margin has improved in the last couple of years.
With a decent Gross Margin value of 49.49%, NYT is doing good in the industry, outperforming 62.50% of the companies in the same industry.
In the last couple of years the Gross Margin of NYT has declined.
Industry RankSector Rank
OM 14.78%
PM (TTM) 11.53%
GM 49.49%
OM growth 3Y3.09%
OM growth 5Y7.54%
PM growth 3Y2.34%
PM growth 5Y8.02%
GM growth 3Y-0.36%
GM growth 5Y-4.15%
NYT Yearly Profit, Operating, Gross MarginsNYT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), NYT is creating some value.
NYT has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, NYT has less shares outstanding
NYT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NYT Yearly Shares OutstandingNYT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
NYT Yearly Total Debt VS Total AssetsNYT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 9.11 indicates that NYT is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 9.11, NYT belongs to the top of the industry, outperforming 95.83% of the companies in the same industry.
There is no outstanding debt for NYT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.11
ROIC/WACC1.49
WACC9.15%
NYT Yearly LT Debt VS Equity VS FCFNYT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

NYT has a Current Ratio of 1.44. This is a normal value and indicates that NYT is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.44, NYT is in line with its industry, outperforming 59.38% of the companies in the same industry.
NYT has a Quick Ratio of 1.44. This is a normal value and indicates that NYT is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.44, NYT is doing good in the industry, outperforming 60.42% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 1.44
NYT Yearly Current Assets VS Current LiabilitesNYT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

NYT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 19.89%, which is quite good.
The Earnings Per Share has been growing by 16.92% on average over the past years. This is quite good.
The Revenue for NYT has decreased by -12.99% in the past year. This is quite bad
The Revenue has been growing slightly by 7.37% on average over the past years.
EPS 1Y (TTM)19.89%
EPS 3Y16.23%
EPS 5Y16.92%
EPS Q2Q%32.26%
Revenue 1Y (TTM)-12.99%
Revenue growth 3Y7.62%
Revenue growth 5Y7.37%
Sales Q2Q%7.05%

3.2 Future

The Earnings Per Share is expected to grow by 10.16% on average over the next years. This is quite good.
The Revenue is expected to grow by 5.68% on average over the next years.
EPS Next Y10.25%
EPS Next 2Y8.62%
EPS Next 3Y9.66%
EPS Next 5Y10.16%
Revenue Next Year6.51%
Revenue Next 2Y6.13%
Revenue Next 3Y5.89%
Revenue Next 5Y5.68%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
NYT Yearly Revenue VS EstimatesNYT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
NYT Yearly EPS VS EstimatesNYT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2 2.5

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 26.26 indicates a quite expensive valuation of NYT.
Compared to the rest of the industry, the Price/Earnings ratio of NYT indicates a somewhat cheap valuation: NYT is cheaper than 63.54% of the companies listed in the same industry.
NYT is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 25.82, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 23.37, which indicates a rather expensive current valuation of NYT.
Compared to the rest of the industry, the Price/Forward Earnings ratio of NYT is on the same level as its industry peers.
NYT's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.76.
Industry RankSector Rank
PE 26.26
Fwd PE 23.37
NYT Price Earnings VS Forward Price EarningsNYT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as NYT.
The rest of the industry has a similar Price/Free Cash Flow ratio as NYT.
Industry RankSector Rank
P/FCF 21.28
EV/EBITDA 17.31
NYT Per share dataNYT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates NYT does not grow enough to justify the current Price/Earnings ratio.
NYT has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.56
PEG (5Y)1.55
EPS Next 2Y8.62%
EPS Next 3Y9.66%

6

5. Dividend

5.1 Amount

NYT has a Yearly Dividend Yield of 1.31%.
Compared to an average industry Dividend Yield of 5.04, NYT pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.39, NYT's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.31%

5.2 History

The dividend of NYT is nicely growing with an annual growth rate of 21.48%!
NYT has been paying a dividend for at least 10 years, so it has a reliable track record.
NYT has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)21.48%
Div Incr Years6
Div Non Decr Years11
NYT Yearly Dividends per shareNYT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

28.49% of the earnings are spent on dividend by NYT. This is a low number and sustainable payout ratio.
The dividend of NYT is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP28.49%
EPS Next 2Y8.62%
EPS Next 3Y9.66%
NYT Yearly Income VS Free CF VS DividendNYT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
NYT Dividend Payout.NYT Dividend Payout, showing the Payout Ratio.NYT Dividend Payout.PayoutRetained Earnings

NEW YORK TIMES CO-A

NYSE:NYT (5/23/2025, 8:41:45 PM)

After market: 55.41 0 (0%)

55.41

+0.52 (+0.95%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)08-05 2025-08-05/bmo
Inst Owners93.87%
Inst Owner Change1.68%
Ins Owners0.68%
Ins Owner Change1%
Market Cap9.03B
Analysts75
Price Target55.5 (0.16%)
Short Float %5.02%
Short Ratio4.37
Dividend
Industry RankSector Rank
Dividend Yield 1.31%
Yearly Dividend0.5
Dividend Growth(5Y)21.48%
DP28.49%
Div Incr Years6
Div Non Decr Years11
Ex-Date04-01 2025-04-01 (0.18)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.32%
Min EPS beat(2)6.49%
Max EPS beat(2)18.14%
EPS beat(4)4
Avg EPS beat(4)10.79%
Min EPS beat(4)6.49%
Max EPS beat(4)18.14%
EPS beat(8)8
Avg EPS beat(8)27.77%
EPS beat(12)12
Avg EPS beat(12)29.35%
EPS beat(16)16
Avg EPS beat(16)26.74%
Revenue beat(2)0
Avg Revenue beat(2)-0.91%
Min Revenue beat(2)-0.99%
Max Revenue beat(2)-0.82%
Revenue beat(4)0
Avg Revenue beat(4)-0.98%
Min Revenue beat(4)-1.09%
Max Revenue beat(4)-0.82%
Revenue beat(8)2
Avg Revenue beat(8)-0.59%
Revenue beat(12)3
Avg Revenue beat(12)-0.56%
Revenue beat(16)6
Avg Revenue beat(16)-0.34%
PT rev (1m)0%
PT rev (3m)-2.86%
EPS NQ rev (1m)1.74%
EPS NQ rev (3m)3.5%
EPS NY rev (1m)3.51%
EPS NY rev (3m)4.48%
Revenue NQ rev (1m)0.29%
Revenue NQ rev (3m)0.16%
Revenue NY rev (1m)0.29%
Revenue NY rev (3m)0.22%
Valuation
Industry RankSector Rank
PE 26.26
Fwd PE 23.37
P/S 3.44
P/FCF 21.28
P/OCF 19.79
P/B 4.79
P/tB 7.41
EV/EBITDA 17.31
EPS(TTM)2.11
EY3.81%
EPS(NY)2.37
Fwd EY4.28%
FCF(TTM)2.6
FCFY4.7%
OCF(TTM)2.8
OCFY5.05%
SpS16.12
BVpS11.56
TBVpS7.48
PEG (NY)2.56
PEG (5Y)1.55
Profitability
Industry RankSector Rank
ROA 11.08%
ROE 16.07%
ROCE 17.82%
ROIC 13.68%
ROICexc 17.99%
ROICexgc 30.06%
OM 14.78%
PM (TTM) 11.53%
GM 49.49%
FCFM 16.16%
ROA(3y)8.59%
ROA(5y)7.74%
ROE(3y)13.1%
ROE(5y)12.23%
ROIC(3y)11.43%
ROIC(5y)10.49%
ROICexc(3y)14.65%
ROICexc(5y)14.2%
ROICexgc(3y)25.48%
ROICexgc(5y)21.57%
ROCE(3y)14.89%
ROCE(5y)13.67%
ROICexcg growth 3Y17%
ROICexcg growth 5Y17.39%
ROICexc growth 3Y3.36%
ROICexc growth 5Y8.52%
OM growth 3Y3.09%
OM growth 5Y7.54%
PM growth 3Y2.34%
PM growth 5Y8.02%
GM growth 3Y-0.36%
GM growth 5Y-4.15%
F-Score8
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 38.26%
Cap/Sales 1.22%
Interest Coverage 250
Cash Conversion 96.71%
Profit Quality 140.13%
Current Ratio 1.44
Quick Ratio 1.44
Altman-Z 9.11
F-Score8
WACC9.15%
ROIC/WACC1.49
Cap/Depr(3y)35.41%
Cap/Depr(5y)44.4%
Cap/Sales(3y)1.22%
Cap/Sales(5y)1.45%
Profit Quality(3y)113.54%
Profit Quality(5y)142.07%
High Growth Momentum
Growth
EPS 1Y (TTM)19.89%
EPS 3Y16.23%
EPS 5Y16.92%
EPS Q2Q%32.26%
EPS Next Y10.25%
EPS Next 2Y8.62%
EPS Next 3Y9.66%
EPS Next 5Y10.16%
Revenue 1Y (TTM)-12.99%
Revenue growth 3Y7.62%
Revenue growth 5Y7.37%
Sales Q2Q%7.05%
Revenue Next Year6.51%
Revenue Next 2Y6.13%
Revenue Next 3Y5.89%
Revenue Next 5Y5.68%
EBIT growth 1Y8.17%
EBIT growth 3Y10.95%
EBIT growth 5Y15.46%
EBIT Next Year30.83%
EBIT Next 3Y16.27%
EBIT Next 5YN/A
FCF growth 1Y133.63%
FCF growth 3Y17.6%
FCF growth 5Y21.42%
OCF growth 1Y111.28%
OCF growth 3Y15.12%
OCF growth 5Y16.67%